--- title: A New Newsletter for Clinical Neurologists | Cureus Blog description: "A new newsletter from Nature Portfolio will cover all that matters for clinical practice in neurology: guideline changes, new evidence, case reports, policy, and regulation." image: https://blog.cureus.com/hubfs/AI-Generated%20Media/Images/Wordmark%20ShiftedImage-1.png --- [![Cureus — Part of Springer Nature](data:image/png;base64,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)](https://www.cureus.com) - [Home](https://www.cureus.com) - [Specialties](https://www.cureus.com/specialties) - [Articles](https://www.cureus.com/articles) - [Specialty Pages](https://www.cureus.com/specialties) - [Posters](https://www.cureus.com/posters) - [Abstracts](https://www.cureus.com/abstracts) - [Collections](https://www.cureus.com/collections) - Resources - [About Peer Review](https://www.cureus.com/about_peer_review) - [About Publishing](https://www.cureus.com/about_publishing) - [About Research Integrity](https://www.cureus.com/research_integrity) - [Channels](https://www.cureus.com/channels) - [About Channels](https://www.cureus.com/channels) - [Cureus Channels Guide](https://www.cureus.com/academic_channels_guide) - [Browse Channels](https://www.cureus.com/channels/all) - [About Us](https://www.cureus.com/about) - [About Cureus](https://www.cureus.com/about) - [Editorial Board](https://www.cureus.com/editorial_board) - [Associate Editors](https://www.cureus.com/associate_editors) - [Academic Council](https://www.cureus.com/academic_council) [Submit Research](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIUze30gran83%2F5iKfzAUPkH22WffugIDc64rInWoxdEWTq1PY7NqbW3OGhWgijdqvW8Ei2q4%2FTug5YDpSgw1Lwd744xWbQOKh0QZsdBVZlz34PoiyLHRXcJR4aW0m2xUYBMTu2pmNX28hhtOKDzJ9lAyLtpqtR2W7mj9KkDQsPvr1QOUtPOnVA32ChLxg%3D&webInteractiveContentId=205845548937&portalId=46589883) - [Blog Home](https://blog.cureus.com) - [Knowledge & Insights](https://blog.cureus.com/blog/tag/knowledge-insights) - [For Authors](https://blog.cureus.com/blog/tag/for-authors) - [For Reviewers](https://blog.cureus.com/blog/tag/for-reviewers) - [For Guest Editors](https://blog.cureus.com/blog/tag/for-guest-editors) - [Community](https://blog.cureus.com/blog/tag/community) - [Call for Submissions](https://blog.cureus.com/blog/tag/call-for-submissions) - [Interviews & Profiles](https://blog.cureus.com/blog/tag/interviews-profiles) - [News](https://blog.cureus.com/blog/tag/news) - [Cureus in the Media](https://blog.cureus.com/blog/tag/cureus-in-the-media) - [Journal News & Updates](https://blog.cureus.com/blog/tag/journal-news-updates) - [Monthly Newsletter](https://blog.cureus.com/blog/tag/monthly-newsletter) - [About This Blog](https://blog.cureus.com/about-this-blog) [Blog Home](https://blog.cureus.com) › [News](https://blog.cureus.com/tag/news) › Introducing “Nature Briefing: Clinical Neurology,” A New Weekly Resource for Clinicians [![Curious in the Media PRP for atopic dermatitis psoriasis](https://blog.cureus.com/hubfs/CITM_PRP-Dermatology-Advisor.png) Cureus Team·September 2, 2026 PRP Improved Every Case, Dermatology Advisor Reports Previous Post](https://blog.cureus.com/prp-atopic-dermatitis-psoriasis) ![](https://blog.cureus.com/hubfs/AI-Generated%20Media/Images/Wordmark%20ShiftedImage-1.png) [Nicola Nosengo](https://blog.cureus.com/author/nicola-nosengo) · September 9, 2026 # Introducing “Nature Briefing: Clinical Neurology,” A New Weekly Resource for Clinicians 6 min read [LinkedIn](https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fblog.cureus.com%2Fnature-briefing-clinical-neurology&title=%3Cspan+id%3D%22hs_cos_wrapper_name%22+class%3D%22hs_cos_wrapper+hs_cos_wrapper_meta_field+hs_cos_wrapper_type_text%22+style%3D%22%22+data-hs-cos-general-type%3D%22meta_field%22+data-hs-cos-type%3D%22text%22+%3EIntroducing+%E2%80%9CNature+Briefing%3A+Clinical+Neurology%2C%E2%80%9D+A+New+Weekly+Resource+for+Clinicians%3C%2Fspan%3E) [X](https://twitter.com/intent/tweet?url=https%3A%2F%2Fblog.cureus.com%2Fnature-briefing-clinical-neurology&text=%3Cspan+id%3D%22hs_cos_wrapper_name%22+class%3D%22hs_cos_wrapper+hs_cos_wrapper_meta_field+hs_cos_wrapper_type_text%22+style%3D%22%22+data-hs-cos-general-type%3D%22meta_field%22+data-hs-cos-type%3D%22text%22+%3EIntroducing+%E2%80%9CNature+Briefing%3A+Clinical+Neurology%2C%E2%80%9D+A+New+Weekly+Resource+for+Clinicians%3C%2Fspan%3E) [Facebook](https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fblog.cureus.com%2Fnature-briefing-clinical-neurology) [Email](mailto:?subject=%3Cspan+id%3D%22hs_cos_wrapper_name%22+class%3D%22hs_cos_wrapper+hs_cos_wrapper_meta_field+hs_cos_wrapper_type_text%22+style%3D%22%22+data-hs-cos-general-type%3D%22meta_field%22+data-hs-cos-type%3D%22text%22+%3EIntroducing+%E2%80%9CNature+Briefing%3A+Clinical+Neurology%2C%E2%80%9D+A+New+Weekly+Resource+for+Clinicians%3C%2Fspan%3E&body=https%3A%2F%2Fblog.cureus.com%2Fnature-briefing-clinical-neurology) If you're a clinician, time is one of your scarcest resources. Patient care rightly takes priority. Administrative tasks, documentation requirements, and multidisciplinary coordination consume hours that could be spent elsewhere. Yet alongside these responsibilities, clinicians face another challenge: staying current with an ever-expanding body of medical knowledge. New therapies enter clinical practice. Guidelines evolve. Diagnostic approaches improve. Research findings emerge that could change how patients are assessed, monitored, or treated. Keeping pace with these developments is essential, but finding the time to do so is not always easy. To help healthcare professionals stay informed, Nature Portfolio has launched *Nature Briefing: Clinical Neurology*, a free weekly newsletter that delivers a concise, curated overview of the most important developments in neurology and related fields. It started on September 3, with new issues arriving every Thursday. [Sign up for Nature Briefing: Clinical Neurology](https://go.springernature.com/int1/briefing/neurology?utm_source=cureus&utm_medium=blog&utm_campaign=nature_briefing_clinical_neurology&utm_content=report_blog_cta) ## Why neurology demands continuous learning Few areas of medicine have experienced as much transformation in recent years as neurology. Historically, many neurological disorders were difficult to diagnose and offered limited therapeutic options. Today, that picture is changing rapidly. Advances in imaging technologies, biomarker research, genomics, artificial intelligence, and drug development are reshaping the field. Conditions that were once managed primarily through symptom control are increasingly benefiting from disease-modifying therapies, targeted interventions, and novel diagnostic tools. Multiple sclerosis provides a clear example of this trend. New imaging approaches, biomarkers, and therapies continue to improve both diagnosis and treatment decisions. Similar progress is being seen in migraine, epilepsy, stroke prevention, neuromuscular disorders, and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. At the same time, clinicians must navigate a rapidly growing evidence base. New clinical trials are published every week. Guidelines and consensus statements are regularly updated. Regulatory decisions can affect treatment availability and standards of care. Research findings often emerge long before they become part of routine clinical practice, making it important for clinicians to understand not only current recommendations but also the innovations that may shape patient care in the years ahead. For neurologists, remaining informed is more than a professional obligation. It is an important part of delivering the best possible care to patients facing complex and often life-altering conditions. [![Nature Briefing Clinical Neurology. A clinician points at brain images on a computer screen.](https://blog.cureus.com/hs-fs/hubfs/nature-briefing_clinical-neurology_banner.jpg?width=1200&height=627&name=nature-briefing_clinical-neurology_banner.jpg)](https://go.springernature.com/int1/briefing/neurology?utm_source=cureus&utm_medium=display&utm_campaign=nature_briefing_clinical_neurology&utm_content=sept_banner) ## A newsletter designed for clinicians Nature Portfolio's *Nature Briefing* newsletters have earned a large and loyal readership by helping people navigate information overload. The portfolio already includes the flagship daily digest of science and technology news, as well as specialist editions covering topics such as cancer, translational research, microbiology, AI and robotics, and the Anthropocene. [*Nature Briefing: Clinical Neurology*](https://go.springernature.com/int1/briefing/neurology?utm_source=cureus&utm_medium=blog&utm_campaign=nature_briefing_clinical_neurology&utm_content=report_blog_cta) builds on that successful model while taking a different approach. Unlike newsletters primarily designed for researchers or general science audiences, this one has been developed specifically with healthcare professionals in mind. Every issue is designed to be read in minutes. Readers receive a carefully selected overview of important developments without having to search across multiple journals, websites, and news sources. ## What you'll find in every issue Each edition of *Nature Briefing: Clinical Neurology* is organized around four core areas. - Clinical research with direct implications for practice: The newsletter highlights studies and evidence that may influence patient care today. This includes major phase III and phase IV clinical trials, systematic reviews, meta-analyses, consensus statements, and guideline updates. - **Noteworthy case studies and diagnostic challenges**: Neurology often presents complex diagnostic challenges. Clinical presentations are frequently nuanced, and unusual cases can provide valuable lessons for practitioners. The newsletter will spotlight notable case reports, diagnostic puzzles, and instructive clinical scenarios that offer practical insights and opportunities for learning. - **Emerging research shaping the future**: Not every important study changes practice immediately. Many innovations begin with early-stage research that points towards future possibilities. The newsletter, therefore, includes selected findings from phase I and phase II trials, along with other emerging research that is driving expert discussion and influencing the direction of the field. - **Developments across the neurology community**: Clinical practice is affected by more than scientific publications. Policy decisions, regulatory approvals, funding initiatives, industry partnerships, and healthcare system developments can all influence patient care. Each issue will include key news from across the neurological community that provides important context for clinicians and healthcare professionals. ## Coverage across the neurological spectrum Neurology encompasses a wide range of disorders, patient populations, and subspecialties. The newsletter has, therefore, been designed to offer broad coverage across the field. Topics will regularly include: - Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease - Multiple sclerosis and other neuroimmunology disorders - Stroke prevention, acute stroke care, and rehabilitation - Epilepsy and seizure disorders - Neuromuscular diseases - Spinal disorders and spinal surgery - Central nervous system infections - Headache and migraine - Sleep disorders - Pediatric neurology The intended audience extends beyond specialist neurologists. Many healthcare professionals encounter neurological conditions as part of their daily practice. Family physicians care for patients with cognitive impairment or dementia. Cardiologists manage patients affected by stroke or cerebrovascular complications. Internists, geriatricians, rehabilitation specialists, psychiatrists, nurse practitioners, physician assistants/associates, and other advanced practice clinicians routinely encounter neurological issues that influence diagnosis, treatment, and long-term care. For these professionals, *Nature Briefing: Clinical Neurology* offers an efficient way to stay connected to developments in a field that increasingly intersects with many other areas of medicine. ## A look at the first edition The [inaugural issue](https://go.springernature.com/-temporary-slug-00c83032-487a-482c-bd4e-c80db688b793?hs_preview=SehfilcH-463860169932), on September 3, offers a glimpse of the breadth and practical relevance readers can expect each week. Among the highlights: - Updated guidelines for migraine prevention by the American Academy of Neurology  - Research showing how the appropriate use of a magnetic resonance imaging (MRI) biomarker may help accelerate the diagnosis of multiple sclerosis. - Evidence-based recommendations suggesting that young survivors of aneurysmal subarachnoid hemorrhage should receive lifelong monitoring because elevated risks may persist even decades after the initial event. - An instructive case study in which an advanced and relatively uncommon imaging technique helped avoid a misdiagnosis in a child presenting with an acute gait disturbance. - New developments in the treatment landscape for Duchenne muscular dystrophy. - Research exploring the causes of sleep disruption in Alzheimer's disease and what those findings could mean for patients and caregivers. [Sign up for Nature Briefing: Clinical Neurology](https://go.springernature.com/int1/briefing/neurology?utm_source=cureus&utm_medium=blog&utm_campaign=nature_briefing_clinical_neurology&utm_content=report_blog_cta) [News](https://blog.cureus.com/tag/news) [Journal News & Updates](https://blog.cureus.com/tag/journal-news-updates) [![A motion blur depiction of an ambulance rushing to a location](https://blog.cureus.com/hubfs/emergency-medicine-research.jpg) Cureus Team·September 15, 2026 Key Research Themes in Emergency Medicine: Triage AI, Trauma Care, and Decision Support Tools Next Post](https://blog.cureus.com/emergency-medicine-research) ## Similar Posts Related reading based on this article's topics [![](https://blog.cureus.com/hubfs/Blog/research-discoverability.png)](https://blog.cureus.com/ai-search-research-discoverability) For Authors September 22, 2026 ### [Medical Research in the Age of AI Search: Improving Research Discoverability and Visibility](https://blog.cureus.com/ai-search-research-discoverability) 8 min read [![Curious in the Media PRP for atopic dermatitis psoriasis](https://blog.cureus.com/hubfs/CITM_PRP-Dermatology-Advisor.png)](https://blog.cureus.com/prp-atopic-dermatitis-psoriasis) Cureus in the Media September 2, 2026 ### [PRP Improved Every Case, Dermatology Advisor Reports](https://blog.cureus.com/prp-atopic-dermatitis-psoriasis) 2 min read [![A pen, a mobile phone, and anatomical figures next to published medical research](https://blog.cureus.com/hubfs/medical-research-blog-hero.jpg)](https://blog.cureus.com/medical-research-publishing-trends) For Authors August 26, 2026 ### [Emerging Trends in Medical Research Publishing](https://blog.cureus.com/medical-research-publishing-trends) 8 min read ## Join the discussion Add your email, first name, and last name to leave a comment. #### Published Content [Specialties](https://www.cureus.com/specialties) [Articles](https://www.cureus.com/articles) [Posters](https://www.cureus.com/posters) [Abstracts](https://www.cureus.com/abstracts) [Collections](https://www.cureus.com/collections) [Channels](https://www.cureus.com/channels/all) [Competitions](https://www.cureus.com/competitions/past_competitions) #### Resources [Cureus Guides](https://www.cureus.com/guides) [Cureus Honors](https://www.cureus.com/honors) [Author Fees](https://www.cureus.com/cureus_editing_services) [SIQ](https://www.cureus.com/siq) [Article Promotion](https://www.cureus.com/article_promotion) [Advertising Policy](https://www.cureus.com/advertising) [Advertise With Us](https://www.cureus.com/ads_sponsorship) [Privacy Policy](https://www.cureus.com/privacy) [US State Privacy Rights](https://www.springernature.com/gp/legal/us-state-privacy-rights) [Terms of Use](https://www.cureus.com/terms) [FAQ](https://www.cureus.com/faq) #### About Us [About Cureus](https://www.cureus.com/about) [Editorial Board](https://www.cureus.com/editorial_board) [Associate Editors](https://www.cureus.com/associate_editors) [About Publishing](https://www.cureus.com/about_publishing) [About Peer Review](https://www.cureus.com/about_peer_review) [About Channels](https://www.cureus.com/channels) [About Collections](https://www.cureus.com/about_collections) [About Competitions](https://www.cureus.com/competitions) [Partnerships](https://www.cureus.com/partnerships) [Careers](https://www.cureus.com/careers) [Sitemap](https://www.cureus.com/sitemap) #### Stay Connected [Contact Us](https://www.cureus.com/contact) [Emails and Alerts](https://www.cureus.com/email_preferences) [LinkedIn](https://www.linkedin.com/company/cureus/) [Facebook](https://www.facebook.com/CureusJournalofMedicalScience/) [X](https://x.com/cureusmedical) [Instagram](https://www.instagram.com/cureusmedical/) [Youtube](https://www.youtube.com/channel/UCtJKOEpL-TGVsq-u8H3sPzQ) [BlueSky](https://bsky.app/profile/cureusmedical.bsky.social) [TikTok](https://www.tiktok.com/@cureusmedical) ### Subscribe to our newsletter for all the latest news and updates Subscribe ISSN: 2168-8184 Public user content licensed [CC-BY 4.0](https://creativecommons.org/licenses/by/4.0/) CUREUS® is a registered trademark of Cureus, Inc. in the United States. ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Nicola Nosengo", "url" : "https://blog.cureus.com/author/nicola-nosengo" }, "dateModified" : "2026-09-09T21:53:33.444Z", "datePublished" : "2026-09-09T18:00:00.000Z", "headline" : "A New Newsletter for Clinical Neurologists | Cureus Blog", "image" : [ "https://blog.cureus.com/hubfs/AI-Generated%20Media/Images/Wordmark%20ShiftedImage-1.png" ], "mainEntityOfPage" : { "@id" : "https://blog.cureus.com/nature-briefing-clinical-neurology", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.cureus.com/hubfs/Logos/Logo%20new%20black.png" }, "name" : "Cureus, Inc." } } ```